The fully linked HTML version of this article has now been published.
Development ePress online publication date 17 Nov 2004
doi: 10.1242/dev.01535
Research article
GDF11 modulates NGN3+ islet progenitor cell number and promotes
-cell differentiation in pancreas development
Erin B. Harmon,
Åsa A. Apelqvist,
Nora G. Smart,
Xueying Gu,
Douglas H. Osborne,
and
Seung K. Kim*
* Author for correspondence (e-mail: seungkim{at}cmgm.stanford.edu)
Identification of endogenous signals that regulate expansion and maturation of organ-specific progenitor cells is a major goal in studies of organ development. Here we provide evidence that growth differentiation factor 11 (GDF11), a member of the TGF-
ligand family, governs the number and maturation of islet progenitor cells in mouse pancreas development. Gdf11 is expressed in embryonic pancreatic epithelium during formation of islet progenitor cells that express neurogenin 3. Mice deficient for Gdf11 harbor increased numbers of NGN3+ cells, revealing that GDF11 negatively regulates production of islet progenitor cells. Despite a marked expansion of these NGN3+ islet progenitors, mice lacking Gdf11 have reduced
-cell numbers and evidence of arrested
-cell development, indicating that GDF11 is also required for
-cell maturation. Similar precursor and islet cell phenotypes are observed in mice deficient for SMAD2, an intracellular signaling factor activated by TGF-
signals. Our data suggest that Gdf11 and Smad2 regulate islet cell differentiation in parallel to the Notch pathway, which previously has been shown to control development of NGN3+ cells. Thus, our studies reveal mechanisms by which GDF11 regulates the production and maturation of islet progenitor cells in pancreas development.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Guo and M. Hebrok
Stem Cells to Pancreatic {beta}-Cells: New Sources for Diabetes Cell Therapy
Endocr. Rev.,
May 1, 2009;
30(3):
214 - 227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Haumaitre, O. Lenoir, and R. Scharfmann
Histone Deacetylase Inhibitors Modify Pancreatic Cell Fate Determination and Amplify Endocrine Progenitors
Mol. Cell. Biol.,
October 15, 2008;
28(20):
6373 - 6383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Schneyer, Y. Sidis, A. Gulati, J. L. Sun, H. Keutmann, and P. A. Krasney
Differential Antagonism of Activin, Myostatin and Growth and Differentiation Factor 11 by Wild-Type and Mutant Follistatin
Endocrinology,
September 1, 2008;
149(9):
4589 - 4595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kondas, G. Szlama, M. Trexler, and L. Patthy
Both WFIKKN1 and WFIKKN2 Have High Affinity for Growth and Differentiation Factors 8 and 11
J. Biol. Chem.,
August 29, 2008;
283(35):
23677 - 23684.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Oliver-Krasinski and D. A. Stoffers
On the origin of the {beta} cell
Genes & Dev.,
August 1, 2008;
22(15):
1998 - 2021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Jorgensen, J. Ahnfelt-Ronne, J. Hald, O. D. Madsen, P. Serup, and J. Hecksher-Sorensen
An Illustrated Review of Early Pancreas Development in the Mouse
Endocr. Rev.,
October 1, 2007;
28(6):
685 - 705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. C. Rulifson, S. K. Karnik, P. W. Heiser, D. ten Berge, H. Chen, X. Gu, M. M. Taketo, R. Nusse, M. Hebrok, and S. K. Kim
Wnt signaling regulates pancreatic beta cell proliferation
PNAS,
April 10, 2007;
104(15):
6247 - 6252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Murtaugh
Pancreas and beta-cell development: from the actual to the possible
Development,
February 1, 2007;
134(3):
427 - 438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mamin and J. Philippe
Activin A Decreases glucagon and arx Gene Expression in {alpha}-Cell Lines
Mol. Endocrinol.,
January 1, 2007;
21(1):
259 - 273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Simeone, L. Zhang, M. K. Treutelaar, L. Zhang, K. Graziano, C. D. Logsdon, and C. F. Burant
Islet hypertrophy following pancreatic disruption of Smad4 signaling
Am J Physiol Endocrinol Metab,
December 1, 2006;
291(6):
E1305 - E1316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bardeesy, K.-h. Cheng, J. H. Berger, G. C. Chu, J. Pahler, P. Olson, A. F. Hezel, J. Horner, G. Y. Lauwers, D. Hanahan, et al.
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.
Genes & Dev.,
November 15, 2006;
20(22):
3130 - 3146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-J. Lee, L. A. Reed, M. V. Davies, S. Girgenrath, M. E. P. Goad, K. N. Tomkinson, J. F. Wright, C. Barker, G. Ehrmantraut, J. Holmstrom, et al.
Regulation of muscle growth by multiple ligands signaling through activin type II receptors
PNAS,
December 13, 2005;
102(50):
18117 - 18122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ge, D. R. Hopkins, W.-B. Ho, and D. S. Greenspan
GDF11 Forms a Bone Morphogenetic Protein 1-Activated Latent Complex That Can Modulate Nerve Growth Factor-Induced Differentiation of PC12 Cells
Mol. Cell. Biol.,
July 15, 2005;
25(14):
5846 - 5858.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2004